Skip to content

Clinical trials

Tuberculosis, Multidrug-Resistant trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tuberculosis, Multidrug-Resistant Country / region: South Africa Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20092
20111
20121
20132
20144
20156
20163
20173
20182
20195
20202
20214
20222
20233
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Unknown status4
Recruiting4
Terminated3
Not yet recruiting2
Withdrawn1
Suspended1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Global Alliance for TB Drug Development6
Medecins Sans Frontieres, Netherlands4
University of Cape Town4
Janssen Infectious Diseases BVBA3
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Boston University2
Centre for the AIDS Programme of Research in South Africa2
Foundation for Innovative New Diagnostics, Switzerland2
Johns Hopkins University2
National Institute of Allergy and Infectious Diseases (NIAID)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tuberculosis, Multidrug-Resistant45
Tuberculosis20
Tuberculosis, Pulmonary12
Extensively Drug-Resistant Tuberculosis11
Bacterial Infections3
HIV Infections2
Mycobacterium Infections2
Acquired Immunodeficiency Syndrome1
Actinomycetales Infections1
Anemia1

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.